ACS Applied Materials & Interfaces · 2019 · 94 citations · 32 references
PharmacyOncologyPharmaceuticsChemotherapyDrug DeliveryTargeted Drug DeliveryBlood-brain Barrier DeliveryBlood-brain Barrier PenetrationBrain Targeted DeliveryCancer Drug DeliveryPeptide DeliveryPeptide Drug DiscoveryBlood-brain Barrier PermeabilityBlood-tumor Barrier PenetrationGlioma ChemotherapyPeptide ConjugatesPeptide-based VectorsPeptide-drug ConjugatesTargeted Delivery Across The Blood-brain BarrierTumor-targeting Peptides
Glioma is the most common malignant tumor of the central nervous system (CNS). Therapeutic efficacy of glioma treatment is greatly limited by the blood-brain barrier (BBB) and blood-brain tumor barrier (BBTB), which restrict the passage of most drugs into the brain and tumors. Developing drug delivery systems that cross the BBB and BBTB will aid in the treatment of glioma and malignant brain metastases. One emerging solution is to identify peptide vectors that penetrate the BBB/BBTB. Herein, a novel BBB/BBTB-penetrating peptide was identified from the phage-displayed peptide library. Peptide-drug conjugates (PDCs) were derived and applied to treat glioma and breast cancer brain metastases. Antitumor activity was achieved in both tumor models with synergistic effects when combined with the currently used chemotherapy drug temozolomide. The peptide reported herein can serve as a universal vector for shuttling compounds across the BBB; therefore, it may have wide applications for treating brain tumors and other CNS diseases.
32
Promotion of microtubule assembly in vitro by taxol
Peter B. Schiff, Jane Fant, Susan Band Horwitz · Nature · 1979 · 3.6K citations
Metastatic Behavior of Breast Cancer Subtypes
Hagen F. Kennecke, Rinat Yerushalmi, Ryan Woods et al. · Journal of Clinical Oncology · 2010 · 2.3K citations · Full text
Medicine, Cancer Biology, Oncology +14
Leptin enters the brain by a saturable system independent of insulin
William A. Banks, Abba J. Kastin, Wei Tao Huang et al. · Peptides · 1996 · 1.2K citations